Showing results (11-20 of 32) with videos related to
Sort By:
Pageof 4
Diagnostic Microbiology and Infectious Disease|June 19, 2007
Validation of the MycoAlign system for Mycobacterium spp. identificationRandall J Olsen, Patricia A Cernoch, Celest M Austin, et al.Frontiers in Oncology|June 27, 2022
Circulating Tumor DNA Testing Supports Rapid Therapeutic Decision-Making in Metastatic Melanoma: A Case ReportTapas Ranjan Behera, Jung Min Song, Jennifer Ko, et al.Journal of Cutaneous Pathology|September 9, 2020
EWSR1-SMAD3 rearranged fibroblastic tumor: Case series and reviewOmar Habeeb, Katelen E Korty, Elizabeth M Azzato, et al.BMC Infectious Diseases|June 20, 2003
Bioelectronic DNA detection of human papillomaviruses using eSensor: a model system for detection of multiple pathogensSuzanne D Vernon, Daniel H Farkas, Elizabeth R Unger, et al.The Journal of Applied Laboratory Medicine|February 4, 2021
Gene Fusion Identification Using Anchor-Based Multiplex PCR and Next-Generation SequencingYu-Wei Cheng, Anders Meyer, Maureen A Jakubowski, et al.Journal of Cutaneous Pathology|April 16, 2020
Targeted next generation sequencing (NGS) to classify melanocytic neoplasmsSamaneh K Zarabi, Elizabeth M Azzato, Zheng Jin Tu, et al.Journal of Cutaneous Pathology|February 7, 2020
Superficial sarcomas with CIC rearrangement are aggressive neoplasms: A series of eight casesJennifer S Ko, Zlatko Marusic, Elizabeth M Azzato, et al.Ophthalmology|March 26, 2013
Inclusion of genotype with fundus phenotype improves accuracy of predicting choroidal neovascularization and geographic atrophyLorah T Perlee, Aruna T Bansal, Karen Gehrs, et al.The Journal of Molecular Diagnostics : JMD|July 10, 2010
The suitability of matrix assisted laser desorption/ionization time of flight mass spectrometry in a laboratory developed test using cystic fibrosis carrier screening as a modelDaniel H Farkas, Nicholas E Miltgen, Jay Stoerker, et al.Archives of Pathology & Laboratory Medicine|April 19, 2022
Most Frequently Cited Accreditation Inspection Deficiencies for Clinical Molecular Oncology Testing Laboratories and Opportunities for ImprovementNikoletta Sidiropoulos, Sarah K Daley, Marian Briggs, et al.Pageof 4